← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2015Last known activity
Sep 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 4 (3 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT05951309Lead sponsorN/ASep 1, 2021
- NCT05943158Lead sponsorN/AJun 1, 2021
- NCT05169138Lead sponsorN/AJan 1, 2021
- NCT05169138Reponsible party - principal investigatorN/AJan 1, 2021
- NCT03672669Lead sponsorN/ANov 5, 2017
- NCT03672669Overall official - principal investigatorN/ANov 5, 2017
- NCT03672669Reponsible party - principal investigatorN/ANov 5, 2017
- NCT03745599Overall official - principal investigatorPhase 4Nov 1, 2017
- NCT03745599Lead sponsorPhase 4Nov 1, 2017
- NCT03745599Reponsible party - principal investigatorPhase 4Nov 1, 2017
- NCT02487329Study directorN/AJan 31, 2015
- NCT02487329Lead sponsorN/AJan 31, 2015
- NCT02487329Reponsible party - principal investigatorN/AJan 31, 2015
Details
- Last known activity
- Sep 1, 2021